Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jessica Jiménez‐Díaz"'
Autor:
Fernando Sebastian‐Valles, Jose Alfonso Arranz Martin, Julia Martínez‐Alfonso, Jessica Jiménez‐Díaz, Iñigo Hernando Alday, Victor Navas‐Moreno, Teresa Armenta Joya, Maria del Mar delFandiño García, Gisela Liz Román Gómez, Jon Garai Hierro, Luis Eduardo Lander Lobariñas, Carmen González‐Ávila, Purificación deMartinez de Icaya, Vicente Martínez‐Vizcaíno, Miguel Antonio Sampedro‐Nuñez, Mónica Marazuela
Publikováno v:
Endocrinology, Diabetes & Metabolism, Vol 8, Iss 1, Pp n/a-n/a (2025)
ABSTRACT Purpose To investigate the impact of clinical and socio‐economic factors on glycaemic control and construct statistical models to predict optimal glycaemic control (OGC) after implementing intermittently scanned continuous glucose monitori
Externí odkaz:
https://doaj.org/article/35d4fa516c68475489be4b5b6385dac0
Autor:
Fernando Sebastian-Valles, Julia Martínez-Alfonso, Jose Alfonso Arranz Martin, Jessica Jiménez-Díaz, Iñigo Hernando Alday, Victor Navas-Moreno, Teresa Armenta Joya, Maria del Mar Fandiño García, Gisela Liz Román Gómez, Jon Garai Hierro, Luis Eduardo Lander Lobariñas, Purificación Martínez de Icaya, Miguel Antonio Sampedro-Nuñez, Vicente Martínez-Vizcaíno, Mónica Marazuela
Publikováno v:
BMC Medicine, Vol 22, Iss 1, Pp 1-11 (2024)
Abstract Background This study investigates the association between socioeconomic status (SES) and glycemic control in individuals with type 1 diabetes (T1D) using flash glucose monitoring (FGM) devices within a public health system where these techn
Externí odkaz:
https://doaj.org/article/bb42fbb09a034775b4163024bfe8e7f0
Autor:
Fernando Sebastian-Valles, José Alfonso Arranz Martín, Rosa María Girón, Carolina Knott-Torcal, Miguel Antonio Sampedro-Nuñez, Jose Carlos Martin-Adan, Jessica Jiménez-Díaz, Mónica Marazuela
Publikováno v:
Biomedicines, Vol 11, Iss 6, p 1754 (2023)
Cystic fibrosis-related diabetes (CFRD) is a complication associated with a negative prognosis in patients with cystic fibrosis (CF). Although the oral glucose tolerance test (OGTT) is the widely recommended screening test for CFRD diagnosis, continu
Externí odkaz:
https://doaj.org/article/f328da5d2daf4995956136a06a2e9d35